Fennec Pharmaceuticals (FENC) Net Cash Flow (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Net Cash Flow of $14.8 million for Q4 2025, up 208.44% year-on-year from $4.8 million in Q4 2024, and up 357.77% on a QoQ basis from $3.2 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Net Cash Flow data on file, last reported at $14.8 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 208.44% year-over-year to $14.8 million; the trailing twelve-month figure through Dec 2025 stood at $10.2 million (down 24.03% YoY), and the FY2025 full-year result was $10.2 million, down 24.03% from the prior year.
- Net Cash Flow for Q4 2025 stood at $14.8 million, up from $3.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $37.9 million in Q1 2024 and bottomed at -$13.7 million in Q4 2024.
- The 5-year median for Net Cash Flow is -$3.3 million (2021), against an average of $73800.0.
- Peak annual rise in Net Cash Flow reached 804.22% in 2024, while the deepest fall reached 1673.1% in 2024.
- A 5-year view of Net Cash Flow shows it stood at -$3.2 million in 2021, then slumped by 84.79% to -$6.0 million in 2022, then soared by 114.55% to $870000.0 in 2023, then sank by 1673.1% to -$13.7 million in 2024, then soared by 208.44% to $14.8 million in 2025.
- The last three Net Cash Flow figures came in at $14.8 million (Q4 2025), $3.2 million (Q3 2025), and -$4.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 14.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.84 Mn |
| Dec 31, 2025 | 14.84 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Jun 30, 2025 | -3.97 Mn |
| Jun 30, 2025 | -3.97 Mn |
| Mar 31, 2025 | -3.96 Mn |
| Mar 31, 2025 | -3.96 Mn |
| Dec 31, 2024 | -13.69 Mn |
| Dec 31, 2024 | -13.69 Mn |
| Sep 30, 2024 | -2.73 Mn |
| Sep 30, 2024 | -2.73 Mn |
| Jun 30, 2024 | -8.13 Mn |
| Jun 30, 2024 | -8.13 Mn |
| Mar 31, 2024 | 37.92 Mn |
| Mar 31, 2024 | 37.92 Mn |
| Dec 31, 2023 | 870,000.00 |
| Dec 31, 2023 | 870,000.00 |
| Sep 30, 2023 | -2.56 Mn |
| Sep 30, 2023 | -2.56 Mn |
| Jun 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -3.43 Mn |
| Mar 31, 2023 | -5.38 Mn |
| Mar 31, 2023 | -5.38 Mn |
| Dec 31, 2022 | -5.98 Mn |
| Dec 31, 2022 | -5.98 Mn |
| Sep 30, 2022 | 14.84 Mn |
| Sep 30, 2022 | 14.84 Mn |
| Jun 30, 2022 | -3.34 Mn |
| Jun 30, 2022 | -3.34 Mn |
| Mar 31, 2022 | -2.84 Mn |
| Mar 31, 2022 | -2.84 Mn |
| Dec 31, 2021 | -3.24 Mn |
| Dec 31, 2021 | -3.24 Mn |
| Sep 30, 2021 | -2.96 Mn |
| Sep 30, 2021 | -2.96 Mn |
| Jun 30, 2021 | -4.43 Mn |
| Jun 30, 2021 | -4.43 Mn |
| Mar 31, 2021 | -3.59 Mn |
| Mar 31, 2021 | -3.59 Mn |
| Dec 31, 2020 | -2.82 Mn |
| Dec 31, 2020 | -2.82 Mn |
| Sep 30, 2020 | -5.56 Mn |
| Sep 30, 2020 | -5.56 Mn |
| Jun 30, 2020 | 28.83 Mn |
| Jun 30, 2020 | 28.83 Mn |
| Mar 31, 2020 | -3.75 Mn |
| Mar 31, 2020 | -3.75 Mn |
| Dec 31, 2019 | -1.59 Mn |
| Dec 31, 2019 | -1.59 Mn |
| Sep 30, 2019 | -2.24 Mn |
| Sep 30, 2019 | -2.24 Mn |
| Jun 30, 2019 | -2.76 Mn |
| Jun 30, 2019 | -2.76 Mn |
| Mar 31, 2019 | -2.55 Mn |
| Mar 31, 2019 | -2.55 Mn |
| Dec 31, 2018 | -1.74 Mn |
| Dec 31, 2018 | -1.74 Mn |
| Sep 30, 2018 | -1.12 Mn |
| Sep 30, 2018 | -1.12 Mn |
| Jun 30, 2018 | -1.08 Mn |
| Jun 30, 2018 | -1.08 Mn |
| Mar 31, 2018 | -1.54 Mn |
| Mar 31, 2018 | -1.54 Mn |
| Dec 31, 2017 | 18.57 Mn |
| Dec 31, 2017 | 18.57 Mn |
| Sep 30, 2017 | -544,000.00 |
| Sep 30, 2017 | -544,000.00 |
| Jun 30, 2017 | 6.98 Mn |
| Jun 30, 2017 | 6.98 Mn |
| Mar 31, 2017 | -675,000.00 |
| Mar 31, 2017 | -675,000.00 |
| Dec 31, 2016 | -611,000.00 |
| Dec 31, 2016 | -611,000.00 |
| Sep 30, 2016 | -544,000.00 |
| Sep 30, 2016 | -544,000.00 |
| Jun 30, 2016 | 4.54 Mn |
| Jun 30, 2016 | 4.54 Mn |
| Mar 31, 2016 | -397,000.00 |
| Mar 31, 2016 | -397,000.00 |
| Dec 31, 2015 | -424,000.00 |
| Dec 31, 2015 | -424,000.00 |
| Sep 30, 2015 | -488,000.00 |
| Sep 30, 2015 | -488,000.00 |
| Jun 30, 2015 | -62,000.00 |
| Jun 30, 2015 | -62,000.00 |
| Mar 31, 2015 | -391,000.00 |
| Mar 31, 2015 | -391,000.00 |
| Dec 31, 2014 | 1.71 Mn |
| Dec 31, 2014 | 1.71 Mn |
| Sep 30, 2014 | -422,000.00 |
| Sep 30, 2014 | -422,000.00 |
| Jun 30, 2014 | -323,000.00 |
| Jun 30, 2014 | -323,000.00 |
| Mar 31, 2014 | -325,000.00 |
| Mar 31, 2014 | -325,000.00 |
| Dec 31, 2013 | 1.13 Mn |
| Dec 31, 2013 | 1.13 Mn |
| Sep 30, 2013 | -469,000.00 |
| Sep 30, 2013 | -469,000.00 |
| Jun 30, 2013 | -889,000.00 |
| Jun 30, 2013 | -889,000.00 |
| Mar 31, 2013 | -407,000.00 |
| Mar 31, 2013 | -407,000.00 |
| Dec 31, 2012 | -557,000.00 |
| Dec 31, 2012 | -557,000.00 |
| Sep 30, 2012 | -726,000.00 |
| Sep 30, 2012 | -726,000.00 |
| Jun 30, 2012 | -1.13 Mn |
| Jun 30, 2012 | -1.13 Mn |
| Mar 31, 2012 | -578,000.00 |
| Mar 31, 2012 | -578,000.00 |
| Dec 31, 2011 | -767,000.00 |
| Dec 31, 2011 | -767,000.00 |
| Sep 30, 2011 | -636,000.00 |
| Sep 30, 2011 | -636,000.00 |
| Jun 30, 2011 | 1.77 Mn |
| Jun 30, 2011 | 1.77 Mn |
| Mar 31, 2011 | -1.05 Mn |
| Mar 31, 2011 | -1.05 Mn |
| Dec 31, 2010 | -655,000.00 |
| Dec 31, 2010 | -655,000.00 |
| Sep 30, 2010 | -550,000.00 |
| Sep 30, 2010 | -550,000.00 |
| Jun 30, 2010 | 6.80 Mn |
| Jun 30, 2010 | 6.80 Mn |